Article
Integrated analysis of cell-free DNA for the early detection of cancer in people with Li-Fraumeni Syndrome
2022-10-11
Abstract excerpt
<h4>Summary</h4> Despite advances in cancer therapeutics, early detection is often the best prognostic indicator for survival ( 1 ). People with Li-Fraumeni syndrome harbor a germline pathogenic variant in the tumor suppressor gene TP53 ( 2 ) and face a near 100% lifetime risk of developing a wide spectrum of, often multiple, cancers ( 3 ). TP53 mutation carriers routinely undergo intensive surveillance protocols...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- a69a5461-c1c5-5c2e-aea9-9abd1b13da19
- DOI
- 10.1101/2022.10.07.22280848
